Rolf W Sparidans Selected Research

Rolf W Sparidans Research Topics

Disease

39	Neoplasms (Cancer) 08/2022 - 11/2002
21	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2010
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2002
7	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2002
6	Brain Neoplasms (Brain Tumor) 01/2019 - 11/2012
4	Neuroblastoma 03/2018 - 01/2014
3	Melanoma (Melanoma, Malignant) 01/2018 - 11/2012
3	Colorectal Neoplasms (Colorectal Cancer) 07/2015 - 01/2010
2	Leukemia 06/2016 - 02/2016
2	Atopic Dermatitis (Atopic Eczema) 02/2012 - 08/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2011 - 02/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2022
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Lymphoma (Lymphomas) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2019
1	Cystinosis 08/2018
1	Disease Progression 08/2018
1	Philadelphia Chromosome 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 03/2017
1	Glioma (Gliomas) 03/2017
1	Carcinoma (Carcinomatosis) 09/2016
1	Retinoblastoma (Glioblastoma, Retinal) 11/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2015
1	Inflammation (Inflammations) 01/2015
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2015

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2010
18	Pharmaceutical PreparationsIBA 08/2022 - 04/2004
15	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021 - 02/2010
7	Tyrosine Kinase InhibitorsIBA 06/2020 - 05/2011
6	Peptides (Polypeptides)IBA 12/2010 - 01/2010
5	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2010
5	Phosphotransferases (Kinase)IBA 01/2022 - 12/2018
5	Anaplastic Lymphoma KinaseIBA 03/2019 - 03/2014
4	TropomyosinIBA 01/2022 - 12/2018
3	larotrectinibIBA 01/2022 - 12/2018
3	Gemcitabine FDA Link 10/2005 - 11/2002
3	Melphalan (Alkeran)FDA LinkGeneric 10/2003 - 11/2002
2	cintirorgonIBA 08/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 04/2004
2	selpercatinibIBA 10/2021 - 06/2020
2	pralsetinibIBA 10/2021 - 06/2020
2	ibrutinibIBA 01/2021 - 11/2018
2	lorlatinibIBA 03/2019 - 10/2018
2	osimertinibIBA 01/2019 - 09/2016
2	ponatinibIBA 10/2017 - 06/2016
2	AfatinibIBA 06/2017 - 02/2016
2	CrizotinibIBA 12/2015 - 03/2014
2	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 11/2015 - 01/2014
2	regorafenibIBA 07/2015 - 10/2014
2	Everolimus FDA Link 06/2014 - 08/2012
2	ElacridarIBA 03/2014 - 11/2012
2	Sorafenib (BAY 43-9006)FDA Link 09/2013 - 02/2010
2	Sunitinib (Sutent)FDA Link 09/2013 - 01/2012
2	Capecitabine (Xeloda)FDA Link 08/2012 - 07/2006
2	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 02/2012 - 08/2010
2	Exopeptidases (Exopeptidase)IBA 12/2010 - 08/2010
2	Trypsin InhibitorsIBA 12/2010 - 08/2010
2	plitidepsin (aplidine)IBA 02/2007 - 06/2005
2	TrabectedinIBA 01/2006 - 10/2005
2	Cisplatin (Platino)FDA LinkGeneric 10/2005 - 09/2003
1	sotorasibIBA 01/2022
1	repotrectinibIBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2021
1	Growth Factor ReceptorsIBA 03/2021
1	selitrectinibIBA 01/2021
1	quizartinibIBA 02/2019
1	AZ5104IBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2018
1	Cytochrome P-450 CYP3AIBA 11/2018
1	brigatinibIBA 11/2018
1	Cystine (L-Cystine)IBA 08/2018
1	Cysteamine (Mercaptamine)FDA Link 08/2018
1	sepantroniumIBA 03/2018
1	Liposomes (Liposome)IBA 03/2018
1	SurvivinIBA 03/2018
1	encorafenibIBA 01/2018
1	MTOR InhibitorsIBA 03/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2017
1	ZSTK474IBA 03/2017
1	dactolisibIBA 03/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2016
1	ceritinibIBA 12/2015
1	Cyclin-Dependent Kinase 2IBA 11/2015
1	NucleophosminIBA 11/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2015
1	acetonitrileIBA 03/2015
1	dabrafenibIBA 03/2015
1	omipalisibIBA 03/2015
1	Biological ProductsIBA 01/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015
1	rucaparibIBA 01/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2015
1	cadherin 5IBA 01/2015
1	CollagenIBA 04/2014

Therapy/Procedure

10	Therapeutics 06/2021 - 04/2004
2	Aftercare (After-Treatment) 11/2015 - 04/2004
2	Oral Administration 03/2015 - 02/2008
1	Combined Modality Therapy 11/2015